High RIG-I and EFTUD2 expression predicts poor survival in endometrial cancer

被引：0
|
作者：
Susanne Beyer
Lena Müller
Sophie Mitter
Lucia Keilmann
Sarah Meister
Christina Buschmann
Fabian Kraus
Nicole E. Topalov
Bastian Czogalla
Fabian Trillsch
Alexander Burges
Sven Mahner
Elisa Schmoeckel
Sanja Löb
Stefanie Corradini
Mirjana Kessler
Udo Jeschke
Thomas Kolben
机构：
[1] University Hospital,Department of Obstetrics and Gynecology
[2] LMU Munich,Institute of Pathology
[3] University Hospital,Department of Gynecology and Obstetrics
[4] LMU Munich,Department of Radiation‑Oncology
[5] University Hospital Wuerzburg,Department of Obstetrics and Gynecology
[6] University Hospital,undefined
[7] LMU Munich,undefined
[8] University Hospital Augsburg,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
RIG-I; DDX58; EFTUD 2; Endometrial cancer; Survival; Innate immune system;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4293 / 4303
页数：10
相关论文
共 50 条
  • [1] High RIG-I and EFTUD2 expression predicts poor survival in endometrial cancer
    Beyer, Susanne
    Mueller, Lena
    Mitter, Sophie
    Keilmann, Lucia
    Meister, Sarah
    Buschmann, Christina
    Kraus, Fabian
    Topalov, Nicole E.
    Czogalla, Bastian
    Trillsch, Fabian
    Burges, Alexander
    Mahner, Sven
    Schmoeckel, Elisa
    Loeb, Sanja
    Corradini, Stefanie
    Kessler, Mirjana
    Jeschke, Udo
    Kolben, Thomas
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (08) : 4293 - 4303
  • [2] EFTUD2 Expression as an independent Marker for Survival in Endometrial Cancer
    Beyer, S.
    Muller, L.
    Keilmann, L.
    Meister, S.
    Buschmann, C.
    Kolben, T. M.
    Schmoeckel, E.
    Burges, A.
    Trillsch, F.
    Czogalla, B.
    Jeschke, U.
    Kessler, M.
    Mahner, S.
    Kolben, T.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (10) : E51 - E51
  • [3] EFTUD2 restricts hepatitis B virus infection by regulating RIG-I expression
    Zhu, C.
    Xiao, F.
    Wang, Q.
    Zhu, T.
    Kong, L.
    Li, J.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S776 - S777
  • [4] EFTUD2 regulates hepatitis C virus replication through the RIG-I/MDA5 pathway
    Zhu, Chuanlong
    Hong, Jian
    Zhao, Lei
    Chusri, Pattranuch
    Jilg, Nikolaus
    Fusco, Dahlene N.
    Schaefer, Esperance A.
    Brisac, Cynthia
    Chevaliez, Stephane
    Wambua, Daniel
    Peng, Lee F.
    Lin, Wenyu
    Chung, Raymond T.
    HEPATOLOGY, 2013, 58 : 306A - 306A
  • [5] EFTUD2 alters hepatitis C virus replication by modulating the RIG-I/MDA5 pathway
    Zhu, Chuanlong
    Hong, Jian
    Fusco, Dahlene
    Brisac, Cynthia
    Schaefer, Esperance A.
    Jeong, Soung Wong
    Peng, Lee F.
    Lin, Wenyu
    Chung, Raymond T.
    HEPATOLOGY, 2014, 60 : 1048A - 1049A
  • [6] EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway
    Zhu, Chuanlong
    Xiao, Fei
    Hong, Jian
    Wang, Kun
    Liu, Xiao
    Cai, Dachuan
    Fusco, Dahlene N.
    Zhao, Lei
    Jeong, Soung Won
    Brisac, Cynthia
    Chusri, Pattranuch
    Schaefer, Esperance A.
    Zhao, Hong
    Peng, Lee F.
    Lin, Wenyu
    Chung, Raymond T.
    JOURNAL OF VIROLOGY, 2015, 89 (13) : 6608 - 6618
  • [7] RIG-I - Expression as a negative prognostic Factor in Endometrial Carcinoma
    Mitter, S.
    Mueller, L.
    Mannewitz, M.
    Keilmann, L.
    Meister, S.
    Kolben, T. M.
    Schmoeckel, E.
    Burges, A.
    Trillsch, F.
    Czogalla, B.
    Mahner, S.
    Kessler, M.
    Jeschke, U.
    Kolben, T.
    Beyer, S.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (06) : 646 - 646
  • [8] EFTUD2 MAINTAINS SURVIVAL OF TUMOR CELLS VIA JAK/STAT3 PATHWAY AND PREDICTS POOR OUTCOMES IN HEPATOCELLULAR CARCINOMA
    Tu, Mengxian
    Yuan, Hui
    Zheng, Dandan
    Xu, Yan
    Liu, Mingyu
    Lin, Zelong
    He, Lu
    Hu, Qiaoting
    Qu, Chen
    Hong, Jian
    HEPATOLOGY, 2019, 70 : 561A - 561A
  • [9] RIG-I as a potential new target for immunotherapies in endometrial cancer
    Mitter, Sophie
    Mueller, Lena
    Mannewitz, Mareike
    Meister, Sarah
    Kolben, Theresa
    Schmoeckel, Elisa
    Burges, Alexander
    Czogalla, Bastian
    Hester, Anna
    Mahner, Sven
    Jeschke, Udo
    Corradini, Stefanie
    Trillsch, Fabian
    Kessler, Mirjana
    Kolben, Thomas
    Beyer, Susanne
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 118 - 118
  • [10] High RIG-I expression in ovarian cancer associates with an immune-escape signature and poor clinical outcome
    Wolf, Dominik
    Fiegl, Heidi
    Zeimet, Alain G.
    Wieser, Verena
    Marth, Christian
    Sprung, Susanne
    Sopper, Sieghart
    Hartmann, Gunther
    Reimer, Daniel
    Boesch, Maximilian
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (07) : 2007 - 2018
12345